EDBI

EDBI, established in 1991, is the corporate venture capital arm of the Singapore Economic Development Board, located in Singapore. The firm specializes in investing in high-growth technology sectors, including Information and Communication Technology, Emerging Technology, and Healthcare, among others. EDBI focuses on supporting companies that aim to expand in Asia and globally, leveraging its extensive network, resources, and expertise to help these businesses achieve their ambitious goals. As a value-creating investor, EDBI provides patient capital to foster growth and innovation across various strategic industries.

Paul Ng

Managing Partner

Jolene Ooi Ph.D

Partner, Investments

Chung Hang Tang

Principal

Heng Tong Choo

Executive Vice President and Executive Board Member

Chu Swee Yeok

CEO and President

Andrew Ekaputra Ph.D

Principal

Christine Giam

Partner

180 past transactions

Callio Therapeutics

Series A in 2025
Callio Therapeutics focuses on developing next-generation, multi-payload antibody-drug conjugates to maximize therapeutic benefits.

Island

Series D in 2024
Island is a cybersecurity startup that specializes in developing an enterprise browser aimed at enhancing productivity while ensuring security. Its platform enables organizations to maintain comprehensive control, visibility, and governance over their online activities, thereby improving overall performance. By focusing on the last mile of cybersecurity, Island helps businesses reduce their cyber footprint and fosters a safe environment for work processes. The solution is designed to balance the need for operational efficiency with robust security measures, ultimately facilitating a seamless workflow for enterprises.

Zinc Money

Seed Round in 2024
Zinc Money provides fast and secure international money transfers, specializing in helping students and individuals send money from India. With the convenience of UPI integration, users can now transfer funds abroad effortlessly. Zinc Money offers quick and affordable money transfer solutions for education, travel, and everyday expenses with transparent fees and strong security. Whether you need to send money internationally or manage global transactions, Zinc simplifies the process, making it an ideal choice for users transferring money from India.

Sunbird Bio

Venture Round in 2024
Sunbird Bio is a diagnostics platform developer focused on advancing molecular diagnostics to deliver faster and more accurate results. Founded by Huilin Shao, the company specializes in detecting a wide array of diseases, including infectious diseases, neurodegenerative disorders, and cancer. By enabling early diagnosis, Sunbird Bio aims to enhance healthcare outcomes and support physicians in making informed decisions. The platform is designed to improve clarity and accessibility in diagnostic testing, thereby contributing to better patient care.

Arta Finance

Venture Round in 2024
Arta Finance is a fintech company established in 2021 by a team of former Google executives, focused on creating a digital family office that democratizes access to wealth management services. By leveraging artificial intelligence and machine learning, Arta aims to provide personalized financial strategies that enable individuals to manage and grow their wealth effectively. Unlike traditional family offices, which often require significant financial commitments and offer high costs, Arta seeks to make comprehensive wealth management accessible to a broader audience. The platform is designed to simplify the financing process, allowing users to engage with financial markets more easily and benefit from services typically reserved for the ultrawealthy.

Riverlane

Series C in 2024
Riverlane is a business focused on developing quantum computing software and engineering instruments to enhance the performance of quantum computers. The company collaborates with quantum computer manufacturers to create essential hardware and software tools that address the challenges posed by unstable qubits and system defects. By designing an ultra-low latency quantum operating system, Riverlane accelerates quantum-classical hybrid algorithms, thereby advancing hardware research and development. Their algorithms are specifically engineered to optimize the utilization of the complete quantum computing stack, helping hardware partners mitigate the system errors that currently hinder the effectiveness of quantum computers. Through these innovative solutions, Riverlane aims to transform experimental quantum technologies into viable commercial products.

ShareChat

Debt Financing in 2024
ShareChat is an Indian social media startup founded in 2015 and headquartered in Bangalore, Karnataka. It provides a content consumption and sharing platform specifically designed for the diverse vernacular audience in India, supporting 15 Indian languages. The platform caters to over 1.17 billion wireless network users in the country, allowing them to share videos, jokes, songs, and other social content. ShareChat includes features for private messaging and tagging, making it easy for users to connect and communicate in their preferred language.

Leo Cancer Care

Series C in 2024
Leo Cancer Care is focused on revolutionizing cancer radiation therapy by offering a treatment system designed to enhance patient experience and outcomes. Founded in Australia, the company leverages global research that highlights the benefits of upright patient positioning during treatment. This innovative approach shifts the traditional paradigm of machine rotation to patient rotation, allowing for a more controlled and efficient therapy process. The system integrates advanced 3D imaging and precise radiation beam management, ensuring that the appropriate amount of energy is delivered to targeted tissues. By streamlining cancer treatment and connecting patients to centralized care centers, Leo Cancer Care aims to reduce both the physical discomfort and costs typically associated with chemotherapy and radiation therapy, ultimately putting patients in control of their treatment journey.

Artera

Venture Round in 2024
Artera develops medical artificial intelligence tests that personalize therapy for cancer patients. Its tests predict therapeutic benefits and prognosticate patient outcomes. The Artera platform is purely software, and runs on digital images of H&E histopathology images as part of routine clinical care.

LXA

Seed Round in 2023
LXA is a fintech venture focused on reimagining Asia's mortgage ecosystem. Geared towards matching institutional capital pools and residential mortgage borrowers, this platform aims to utilize end-to-end technology to streamline the entire mortgage lifecycle, from loan origination and borrower processing to loan servicing. LXA was founded in early 2023 by seasoned executives across the asset management, insurance, mortgage, and technology industries to bridge the gap between mortgage assets and institutional capital in Asia, beginning with Singapore. Combining best practices from North American and European markets with a proprietary technology platform focused on digital credit decisioning and intelligent workflow orchestration, LXA provides the first of its kind solution to address strong demand from Asian insurers and borrowers for differentiated mortgage products.

Engine Biosciences

Series A in 2023
Engine Biosciences is a biotech company focused on revolutionizing drug discovery through the application of machine learning and network biomedicine. Based in San Francisco and Asia, the company has developed a proprietary platform that combines high-throughput wet lab experimentation with advanced artificial intelligence algorithms. This platform is designed to map and analyze complex biological networks, generating unique data on gene interactions and providing insights validated through controlled experiments. By doing so, Engine Biosciences aims to accelerate research and development processes and reduce costs associated with creating new medical therapies. The company collaborates with various partners and actively applies its technology to address a range of disease indications, leveraging the expertise of its scientific leadership team, which includes faculty members from renowned institutions such as MIT, Harvard, and the Mayo Clinic.

Automera

Series A in 2023
Automera is engaged in the development of innovative therapeutic methods for drug creation. The company specializes in an autophagy-targeting drug designed to address specific diseases. Utilizing advanced computational chemistry, artificial intelligence, and quantum molecular dynamics, Automera's technology focuses on designing chimeric small molecules. These molecules are engineered to bind simultaneously to autophagy processes and specific disease targets, functioning as natural defense mechanisms against viruses and bacteria. This approach enables clients to identify and develop effective drugs that harness the body's autophagy capabilities.

Endowus

Series C in 2023
Endowus is a financial advisory and personalized investment company focused on helping clients grow their wealth. It offers access to institutional share-class funds typically reserved for large investors, allowing retail investors to benefit from lower fees associated with institutional-level investments. The company provides a comprehensive service that includes financial advice, investment management, portfolio rebalancing, and brokerage services, all under a single access fee. By connecting clients with funds managed by reputable global investment management firms, Endowus aims to deliver attractive returns and financial growth opportunities that are usually unavailable to individual investors.

Mirxes

Series D in 2023
Mirxes is a biotechnology company that discovers, develops, and delivers accurate preventive healthcare solutions for cancer, cardiovascular, metabolic and infectious diseases. The company's mission is to make diagnostic solutions for the early detection of diseases accessible on a global scale. It develops and commercializes accurate and non-invasive blood-based miRNA test kit products for the early detection of cancer and other diseases.

Engine Biosciences

Series A in 2023
Engine Biosciences is a biotech company focused on revolutionizing drug discovery through the application of machine learning and network biomedicine. Based in San Francisco and Asia, the company has developed a proprietary platform that combines high-throughput wet lab experimentation with advanced artificial intelligence algorithms. This platform is designed to map and analyze complex biological networks, generating unique data on gene interactions and providing insights validated through controlled experiments. By doing so, Engine Biosciences aims to accelerate research and development processes and reduce costs associated with creating new medical therapies. The company collaborates with various partners and actively applies its technology to address a range of disease indications, leveraging the expertise of its scientific leadership team, which includes faculty members from renowned institutions such as MIT, Harvard, and the Mayo Clinic.

Moloco

Secondary Market in 2023
Moloco Inc., founded in 2013 and based in Palo Alto, California, specializes in programmatic advertising solutions aimed at optimizing client acquisition, retention, and monetization strategies. The company offers a cloud-based demand-side platform that leverages machine learning to help businesses of all sizes enhance user acquisition and maximize lifetime value through predictive models. Additionally, Moloco provides a mobile e-commerce platform that supports targeted re-engagement campaigns, allowing application publishers and e-commerce platforms to expand their customer reach more effectively than traditional advertising methods. With a team comprised of top talents from leading tech firms, Moloco is committed to empowering mobile businesses to thrive in a competitive landscape.

EdgeQ

Series B in 2023
EdgeQ Inc. is an information technology company that develops and manufactures open and programmable 5G system-on-a-chip solutions. Founded in 2018 and headquartered in Santa Clara, California, with additional locations in San Diego and Bangalore, EdgeQ specializes in converged connectivity and artificial intelligence that is fully customizable through software. The company's offerings cater to a variety of industries, including manufacturing, construction, energy, automotive, warehousing, surveillance, and telecommunications. EdgeQ's technology facilitates applications such as collaborative robotics, automated guided vehicles, autonomous driving, traffic management, and digital twins, empowering enterprises to leverage private networking for innovative services and business models.

Thunes

Series C in 2023
Thunes is a global B2B payment infrastructure platform established in 2016, specializing in cross-border payment solutions. It facilitates seamless fund transfers between various payment systems, catering to a diverse range of clients, including major players in the gig economy and fintech sectors. The platform enables businesses and consumers to send and receive payments in 80 currencies across 132 countries, supporting 300 payment methods. Thunes offers a suite of services including remittance processing, mass payouts, virtual accounts, and payment collection, utilizing application programming interfaces (APIs) to enhance accessibility and reduce transaction costs. In April 2022, the company expanded its capabilities by acquiring a controlling stake in Tookitaki, a compliance platform that strengthens its anti-money laundering and fraud prevention measures. Headquartered in Singapore, Thunes operates regional offices in key global cities such as London, Paris, and Dubai, positioning itself as a vital player in the international payment landscape.

Proxtera

Seed Round in 2023
Proxtera operates a global trading network platform aimed at simplifying cross-border trade and supporting micro, small, and medium enterprises (MSMEs). The platform leverages artificial intelligence to identify pricing and sales opportunities, facilitating access to diverse supply chains. By integrating digital and financial technologies, Proxtera enhances the capabilities of digital service providers and trade associations, promoting the digital transformation of small and medium enterprises. This approach improves the accessibility, availability, and affordability of innovative digital solutions, ultimately fostering a more inclusive global marketplace for MSMEs.

LionsBot

Series A in 2023
LionsBot International is a Singapore-based robotics company specializing in the development of autonomous cleaning robots for commercial, industrial, and public spaces. The company focuses on creating highly versatile cleaning solutions by integrating advanced technology, including human-centered AI, 3D LiDAR sensors, and auto-docking mechanics. These innovations enable their robots to efficiently vacuum and scrub large areas, significantly enhancing cleaning speed and effectiveness. All software and hardware are developed in-house, ensuring comprehensive knowledge and support for their products. LionsBot aims to transform everyday living for over 50 million people by providing smart cleaning robots that are reliable and user-friendly.

Doctor Anywhere

Series C in 2022
Doctor Anywhere is a Singapore-based telehealth company that offers a comprehensive digital platform for on-demand healthcare solutions. It provides quick access to a range of health and wellness services, allowing users to consult licensed medical professionals for diagnoses, medications, and e-prescriptions from anywhere and at any time. The platform is designed to be simple and convenient, catering to the evolving lifestyle preferences of modern users. By leveraging technology, Doctor Anywhere aims to enhance health outcomes and address contemporary healthcare challenges, making it easier for individuals to manage their health according to their specific needs.

Resolve BioSciences

Series B in 2022
Resolve BioSciences GmbH, founded in 2016 and based in Monheim am Rhein, Germany, specializes in spatial multiomics analysis platforms that enhance the understanding of single-cell spatial biology. The company's technology offers a comprehensive, high-resolution view of subcellular gene expression activities, which is crucial for advancements in various fields such as oncology, neuroscience, and infectious diseases. Resolve BioSciences provides a range of services and expertise in bioinformatics, imaging, genomics, transcriptomics, histology, and pathology, among other areas. This innovative approach supports researchers in their efforts to explore complex biological systems and improve outcomes in health and agriculture.

Structo

Venture Round in 2022
Structo is a digital manufacturing platform specializing in dental 3D printing services. The company has developed a range of application-specific 3D printing resins that complement its advanced hardware technology. By focusing on designing and implementing proprietary technology, Structo offers 3D printers that operate at higher speeds than traditional SLA printers. This innovative approach enables dental businesses to enhance their digital dentistry practices, achieving greater throughput and cost efficiency while maintaining high print quality.

ImmunoScape

Venture Round in 2022
ImmunoScape is a company specializing in immunomics, focusing on immune profiling and the characterization of the human immune response with high precision. Its Deep Immunomics platform integrates advanced technologies such as mass cytometry, single cell sequencing, and proprietary computational bioinformatics to deliver detailed immune profiling information. This platform is particularly valuable in therapeutic areas like oncology and infectious diseases, where it aids in understanding the safety and efficacy of immunotherapies and in identifying potential drug targets. Additionally, ImmunoScape offers a software suite that includes immune cell profiling technologies and antigen-specific T-cell identification, providing crucial insights for companies involved in the research and clinical development of immunotherapies.

Fazz

Series C in 2022
Fazz is a financial technology company based in Singapore and Indonesia, founded in 2016. It focuses on providing digital financial services to enhance financial inclusion across Southeast Asia, particularly targeting underserved segments such as micro and small enterprises. Fazz offers a range of services including payment processing, banking, and investment solutions tailored for small businesses, startups, and large corporations. Its flagship offerings include Fazz Agen, an agent-based financial application designed for micro and small businesses, and Fazz Business, a comprehensive business account that facilitates payments, capital growth, and funding opportunities. The merger of PayFazz and Xfers has strengthened Fazz's position in the fintech landscape, enabling it to deliver diverse financial services to consumers and businesses alike.

Pico

Private Equity Round in 2022
Pico is a prominent provider of technology services tailored for the financial markets sector. The company offers a comprehensive network platform that enables clients to access financial markets instantly. This platform is enhanced with advanced analytics and telemetry capabilities, ensuring transparency and low-latency solutions. Pico's innovative approach allows clients to operate efficiently and gain a competitive advantage in the rapidly evolving financial landscape. Its agile service delivery model further supports the needs of clients seeking to navigate the complexities of financial trading effectively.

Wefox

Series D in 2022
Wefox is a technology company specializing in the insurance sector. It operates a digital platform that connects insurance providers, brokers, businesses, and customers, facilitating access to various insurance solutions. The company focuses on indirect sales, partnering with intermediaries to expand its market reach. Wefox's platform offers services such as policy management, claims settlement, and quotation generation for a range of insurance types, including health, liability, and disability.

DataStax

Private Equity Round in 2022
DataStax, Inc. is a provider of database software specifically designed for cloud applications, catering to Fortune 100 companies both in the United States and internationally. The company offers a range of products including DataStax Enterprise, which is based on Apache Cassandra and supports online applications requiring high performance and reliability. Additionally, DataStax provides tools such as OpsCenter for database management and monitoring, K8ssandra for deploying Cassandra on Kubernetes, and Astra, a database-as-a-service that significantly reduces deployment time. With a focus on real-time processing, DataStax also enables the building of generative AI applications through its vector database, which supports developers with various integration capabilities. The company's services are complemented by training, certification, support, and consulting. Founded in 2010 and headquartered in Santa Clara, California, DataStax has expanded its presence with offices in multiple global locations including the United Kingdom, Japan, France, Germany, Australia, and Ireland.

Tessa Therapeutics

Series A in 2022
Tessa Therapeutics is a biotechnology company specializing in T cell therapy aimed at treating cancer, particularly solid tumors and lymphoma. The company focuses on developing both autologous and allogeneic cell therapies, including virus-specific T-cells and CAR T cells. Tessa Therapeutics aims to harness the body's anti-viral immune response to target and eliminate cancer cells, thereby transforming cancer treatment and enhancing the quality of life for patients. Through its innovative platform, Tessa Therapeutics is committed to advancing therapeutic options for healthcare providers and improving patient outcomes in the fight against cancer.

Neuron Mobility

Series B in 2022
Neuron Mobility is a rental e-scooter company focused on providing safe and convenient urban transportation. The company offers a fleet of distinctive orange e-scooters and e-bikes, which are designed and manufactured in-house to meet commercial standards, ensuring durability and performance that surpasses standard models. Utilizing high-accuracy location technology and rapid geofence detection, Neuron Mobility actively monitors rider behavior to enhance safety. Their platform integrates real-time telematics, facilitating personal mobility for daily commuting, goods delivery, and tourism, thus enabling users to access safe, comfortable, and affordable transport for short-distance travel.

RVAC Medicines

Series B in 2022
RVAC Medicines is an mRNA platform company founded in 2021 and based in Singapore. It focuses on developing a diverse pipeline of innovative vaccines and therapeutics to address unmet medical needs, particularly in emerging markets. The company is dedicated to producing cutting-edge mRNA and nucleic acid delivery technologies through its advanced GMP manufacturing facilities. RVAC Medicines offers end-to-end manufacturing capabilities and supports process scale-up and technology transfer, allowing for the development of both single and multi-mRNA/DNA products. This infrastructure aims to empower healthcare professionals in their efforts to combat infectious diseases.

Biofourmis

Series D in 2022
Biofourmis is a biotechnology company based in Boston, Massachusetts, founded in 2015. It specializes in personalized care and therapies through the use of digital therapeutics. The company develops and delivers clinically validated software-based therapeutics that enhance patient outcomes. Biofourmis has created a predictive health analytics platform that analyzes physiology data gathered from clinical-grade wearables. Utilizing artificial intelligence, this platform integrates and interprets continuous physiological data to identify personalized patterns and predict potential clinical exacerbations. By enabling medical professionals to intervene days before critical events occur, Biofourmis aims to improve patient care and provide cost-effective solutions for healthcare providers.

Us2.ai

Series A in 2022
Us2.ai is a Singapore-based company that develops artificial intelligence-driven software and digital tools specifically for echocardiography. The company offers online solutions that streamline access to results from echocardiogram analyses and heart ultrasounds. Its machine learning platform automates the traditionally manual process of measuring and interpreting echocardiograms, enhancing the efficiency of cardiovascular research and clinical trials. By providing AI-based decision support tools, Us2.ai aims to save physicians time, improve the accuracy of clinical trials for pharmaceutical companies, and assist in the detection of conditions that are often overlooked or difficult to diagnose in hospital settings.

Maya

Convertible Note in 2022
Maya is a Philippines-based technology company and a wholly-owned subsidiary of Smart Communications, Inc., under the umbrella of First Pacific. The company specializes in providing innovative digital solutions aimed at developing new business streams and adapting to evolving business models. Maya offers a comprehensive range of services, including merchant acquiring, domestic and international remittance, payment acceptance, card issuing, and various digital financial services. Additionally, the company focuses on mobile payments, digital disbursement, e-wallets, digital lending, and digital banking, positioning itself as a key player in the financial technology sector.

Beam

Series B in 2022
Beam Mobility Holdings Pte. Ltd. is a micro-mobility company that offers electric scooters for rent through a user-friendly mobile application. Established in 2018 and based in Singapore, Beam aims to enhance urban mobility by providing a network of shared e-scooters that can be easily accessed on a pay-per-use basis. The company promotes responsible parking by incentivizing users to return scooters to designated parking spots, thereby minimizing clutter on city streets. By leveraging Internet of Things technology, Beam contributes to improved last-mile connectivity, helps alleviate traffic congestion, and supports environmental sustainability efforts.

Mirxes

Series C in 2022
Mirxes is a biotechnology company that discovers, develops, and delivers accurate preventive healthcare solutions for cancer, cardiovascular, metabolic and infectious diseases. The company's mission is to make diagnostic solutions for the early detection of diseases accessible on a global scale. It develops and commercializes accurate and non-invasive blood-based miRNA test kit products for the early detection of cancer and other diseases.

Modalku

Series C in 2022
Modalku is an online marketplace based in Jakarta, Indonesia for small businesses to acquire loans and for lenders to fund small business loans to earn compelling returns. Its technology-based approach enables borrowers to receive loans for the first time or at lower than market rates, while lenders will earn returns well above that of bank deposits, traditional fixed income products, and life insurance investment-linked products. This marketplace lending model is proven in countries such as USA, UK, China & Singapore.

Funding Societies

Series C in 2022
Funding Societies, established in 2015 and headquartered in Singapore, operates a digital financing platform that connects small and medium-sized enterprises (SMEs) with investors. The company facilitates business loans, focusing on quick and efficient financing solutions, often bypassing traditional banking methods. It offers a range of flexible financing options, including micro and term loans, and invoice financing, using advanced credit scoring and risk assessment models. With operations across Southeast Asia, including Singapore, Malaysia, Indonesia, and Thailand, Funding Societies caters to SMEs seeking accessible and timely financing.

Next Gen Foods

Series A in 2022
Next Gen Foods is a food-tech startup that offers plant-based meat products. Its plant-based products look and taste like meat and are developed using agricultural food ecosystems helping consumers to have foods that are rich in protein and nutrients. The company was founded in 2020 and is headquartered in Singapore.

Hazel Technologies

Venture Round in 2022
Hazel Technologies, Inc. is a biotechnology company focused on reducing waste in the agricultural supply chain through innovative packaging solutions. Founded in 2015 and headquartered in Chicago, Illinois, with an additional location in Salinas, California, the company designs packaging inserts, known as sachets, that are placed in produce boxes at harvest. These sachets slow down the aging process of fruits and vegetables by controlling the storage atmosphere and inhibiting ethylene, which helps to extend shelf life and prevent spoilage. Hazel Technologies also offers horticultural consulting services to growers and shippers, working to improve the efficiency of the fresh produce supply chain. Their product development is supported by the United States Department of Agriculture, with performance validated by third-party research institutions. By providing effective shelf-life extension technologies and services, Hazel Technologies aims to combat global food waste and enhance profitability for its customers.

Sleek

Series A in 2021
Sleek is a digital platform that offers comprehensive corporate services aimed at facilitating company registration, compliance, and financial management for small and medium enterprises. The company simplifies business operations by providing a range of services, including company incorporation, accounting, tax management, payroll, and regulatory compliance. By automating administrative tasks that can often hinder entrepreneurs, Sleek enables clients to efficiently manage their business governance online. Its mission is to enhance the entrepreneurial experience by streamlining processes and reducing the complexity associated with starting and running a business.

bolttech

Series A in 2021
Bolttech is an international InsurTech company specializing in AI-driven point-of-sale insurance solutions. Its platform offers a wide range of insurance products including device protection, travel, motor, property, life, and digital insurance to consumers worldwide, with a significant presence in Asia. Bolttech's technology enables seamless connections between insurers, distributors, and customers, facilitating efficient buying and selling of insurance products.

Ember

Series E in 2021
Ember Technologies is a design-focused temperature control brand that aims to transform how people eat and drink. Founded by inventor Clay Alexander, Ember develops patented temperature-adjustable products, such as the Ember Travel Mug² and Ember Mug², which allow users to set and maintain their preferred drinking temperature for hot beverages. These innovative mugs enhance the flavor of coffee and tea by enabling complete temperature customization, thereby improving the overall drinking experience. Ember's products have received recognition, including being named one of TIME magazine’s Best Inventions. The company's temperature control technology is also being expanded into new sectors, including healthcare and infant feeding, and its products are available at major retailers like Best Buy, Apple, and Target.

Endowus

Venture Round in 2021
Endowus is a financial advisory and personalized investment company focused on helping clients grow their wealth. It offers access to institutional share-class funds typically reserved for large investors, allowing retail investors to benefit from lower fees associated with institutional-level investments. The company provides a comprehensive service that includes financial advice, investment management, portfolio rebalancing, and brokerage services, all under a single access fee. By connecting clients with funds managed by reputable global investment management firms, Endowus aims to deliver attractive returns and financial growth opportunities that are usually unavailable to individual investors.

ShopBack

Series E in 2021
ShopBack is a leading online shopping platform in Southeast Asia that focuses on enhancing consumer purchasing decisions through cashback and rewards. Operating in several countries including Singapore, Malaysia, Indonesia, the Philippines, Thailand, and Taiwan, the company facilitates over 1,000 orders per hour by offering up to 30% cashback on purchases made through its platform. With a portfolio of over 1,300 merchant partners such as Uber, Expedia, and Lazada, ShopBack provides consumers with curated deals while simultaneously delivering effective marketing solutions for its business partners. The company is recognized for its impact in the industry, having received multiple awards, including accolades for Best Start-up and Best Innovative Infocomm Products at the Singapore Infocomm Technology Federation Awards, as well as the Emerging Enterprise Award, highlighting its role in enriching the shopping experience for consumers.

Advance Intelligence Group

Series D in 2021
Advance Intelligence Group is a financial technology firm that builds an ecosystem of AI-powered, credit-enabled products, and services. Founded in 2016, it leverages innovative technology and partnerships to build an ecosystem of products and services serving consumers, enterprises, and merchants.

Neuroglee Health

Series A in 2021
Neuroglee Health is a digital therapeutic platform focused on treating patients in the early stages of neurodegenerative diseases. The company develops therapeutic devices that aim to preserve cognitive function and independence for individuals facing these conditions. By utilizing cognitive and neurobehavioral mechanisms, Neuroglee's tools engage users on a personal level and provide consistent insights into the efficacy of treatments. This approach not only empowers patients in managing their health but also supports accelerated drug development through effective monitoring. Through its innovative solutions, Neuroglee Health seeks to enhance the quality of life for those affected by neurodegenerative disorders.

Nature's Fynd

Series C in 2021
Nature's Fynd is a Chicago-based food company that specializes in producing a unique protein derived from a microbe found in geothermal springs. Founded in 2012 and originally known as Sustainable Bioproducts, Inc., the company focuses on creating sustainable food options that benefit both consumers and the environment. Utilizing innovative fermentation technology, Nature's Fynd is able to cultivate protein using significantly less land and water compared to conventional agricultural methods. The company also operates an additional office in Bozeman, Montana, and aims to contribute to a more sustainable food system through its revolutionary approach to protein production.

Mirxes

Series C in 2021
Mirxes is a biotechnology company that discovers, develops, and delivers accurate preventive healthcare solutions for cancer, cardiovascular, metabolic and infectious diseases. The company's mission is to make diagnostic solutions for the early detection of diseases accessible on a global scale. It develops and commercializes accurate and non-invasive blood-based miRNA test kit products for the early detection of cancer and other diseases.

AvePoint

Post in 2021
AvePoint, Inc. is a leading provider of software solutions and services designed for users of SharePoint and Office 365, focusing on data migration, management, and protection. Founded in 2001 and headquartered in Jersey City, New Jersey, the company serves over 21,000 customers globally, ensuring data security and compliance across various cloud environments, including Microsoft, Google, and Salesforce. AvePoint offers a range of products, including compliance solutions that address privacy and information security risks, as well as tools for data protection, operational governance, and records management. Its Confidence Platform provides cloud-based solutions for IT operations, development operations, and cybersecurity, facilitating secure collaboration and digital transformation. The company's extensive partner program includes over 3,500 managed service providers and systems integrators, making its solutions available in more than 100 cloud marketplaces.

SCI Ecommerce

Venture Round in 2021
SCI Ecommerce specializes in digital commerce solutions, offering a range of services designed to enhance online marketing efforts. The company focuses on creating data-driven, user-specific marketing campaigns that help clients connect with their target audiences and grow their businesses. SCI Ecommerce's offerings include the development of online storefronts and high-quality content creation that aligns with clients' branding objectives. Additionally, the company provides marketing services aimed at increasing brand awareness and conversion rates, ultimately driving sales across various platforms. By assisting clients in navigating the complexities of the supply chain, SCI Ecommerce helps them improve profitability and operational efficiency.

Nuevocor

Series A in 2021
Nuevocor is a preclinical-stage biopharmaceutical company dedicated to developing gene therapy-based treatments aimed at restoring cardiac function in patients with cardiovascular diseases. The firm specifically targets genetic cardiomyopathies, which are characterized by abnormal mechanobiology. By focusing on modulating mechanical force transduction, Nuevocor aims to provide innovative solutions that enable healthcare professionals to effectively treat these conditions and improve heart health in affected individuals.

Engine Biosciences

Series A in 2021
Engine Biosciences is a biotech company focused on revolutionizing drug discovery through the application of machine learning and network biomedicine. Based in San Francisco and Asia, the company has developed a proprietary platform that combines high-throughput wet lab experimentation with advanced artificial intelligence algorithms. This platform is designed to map and analyze complex biological networks, generating unique data on gene interactions and providing insights validated through controlled experiments. By doing so, Engine Biosciences aims to accelerate research and development processes and reduce costs associated with creating new medical therapies. The company collaborates with various partners and actively applies its technology to address a range of disease indications, leveraging the expertise of its scientific leadership team, which includes faculty members from renowned institutions such as MIT, Harvard, and the Mayo Clinic.

Esco Lifesciences

Series A in 2021
Esco Lifesciences Group specializes in providing technology-based products and services tailored for the life sciences and healthcare sectors. The company supports a range of activities, including academic research, scientific discovery, clinical practice, and biopharmaceutical research and development. By offering innovative solutions, Esco Lifesciences aims to facilitate the invention, discovery, and commercialization of advancements in these fields, ultimately contributing to improved health and safety for individuals.

Hummingbird Bioscience

Series C in 2021
Hummingbird Bioscience is a biotechnology company specializing in the development of novel therapeutic antibodies for oncology and immuno-oncology indications. Utilizing systems biology approaches and proprietary computational platforms, they discover and engineer innovative biotherapeutics targeting challenging disease pathways with strong biological validation. Their pipeline includes lead assets HMBD-001 (anti-HER3) and HMBD-002 (anti-VISTA), both in cancer treatment. The company has formed strategic partnerships with Cancer Research UK and Amgen, and received a product development grant from the Cancer Prevention and Research Institute of Texas.

VNLIFE

Venture Round in 2021
VNLIFE is a technology company that develops a digital ecosystem for the tourism, logistics, and commerce sector. It enables a full suite of digital products on their payment and service platforms for individual consumers. The company's mission statement is to become the enabler to startups in terms of technical expertise, business guidance, building networks, and capital so as to provide these startups unprecedented opportunity not only to grow their products and services in the domestic market but also to compete in the global arena.

Neon Group

Private Equity Round in 2021
Neon Group is a global entertainment company headquartered in Singapore, specializing in creating and producing immersive experiences across various domains, including exhibitions, events, and interior architecture. The company has established partnerships with prominent organizations, including The Walt Disney Company, Marvel Entertainment, 20th Century Studios, and NBCUniversal, to develop popular themed exhibitions such as Marvel Avengers S.T.A.T.I.O.N. and Jurassic World: The Exhibition. Additionally, Neon collaborates with the governments of Peru and Egypt to present unique cultural experiences, showcasing original artifacts through exhibitions like Machu Picchu and Ramses the Great. With a commitment to delivering compelling and memorable experiences, Neon Group has successfully engaged millions of visitors across more than 60 cities worldwide, solidifying its position as a leader in the immersive entertainment industry.

ImmunoScape

Venture Round in 2021
ImmunoScape is a company specializing in immunomics, focusing on immune profiling and the characterization of the human immune response with high precision. Its Deep Immunomics platform integrates advanced technologies such as mass cytometry, single cell sequencing, and proprietary computational bioinformatics to deliver detailed immune profiling information. This platform is particularly valuable in therapeutic areas like oncology and infectious diseases, where it aids in understanding the safety and efficacy of immunotherapies and in identifying potential drug targets. Additionally, ImmunoScape offers a software suite that includes immune cell profiling technologies and antigen-specific T-cell identification, providing crucial insights for companies involved in the research and clinical development of immunotherapies.

vArmour

Venture Round in 2021
VArmour is a cybersecurity company based in Mountain View, California, founded in 2011. It specializes in perimeter security solutions tailored for mobile, virtual, and cloud environments. The company develops security applications that protect critical applications and workloads across multi-cloud infrastructures, with a focus on organizations in heavily regulated industries. VArmour’s tools help users secure and manage data and security policies across both public and private cloud environments, offering a centralized approach to safeguarding applications and data.

Pico

Series C in 2020
Pico is a prominent provider of technology services tailored for the financial markets sector. The company offers a comprehensive network platform that enables clients to access financial markets instantly. This platform is enhanced with advanced analytics and telemetry capabilities, ensuring transparency and low-latency solutions. Pico's innovative approach allows clients to operate efficiently and gain a competitive advantage in the rapidly evolving financial landscape. Its agile service delivery model further supports the needs of clients seeking to navigate the complexities of financial trading effectively.

Pear Therapeutics

Series D in 2020
Pear Therapeutics, Inc. is a healthcare company specializing in the discovery, development, and delivery of software-based therapeutics aimed at treating behavioral health disorders, including addiction, schizophrenia, anxiety, depression, and chronic insomnia. Founded in 2013 and headquartered in Boston, with an additional office in San Francisco, Pear Therapeutics offers a range of digital therapies designed to enhance treatment outcomes. Notable products include reSET, a tool for substance abuse treatment used alongside traditional therapy; reSET-O, which addresses opioid use disorder; and Somryst, aimed at chronic insomnia. The company also provides PearConnect, a patient services center that connects users with advocates, clinicians, and insurance providers to facilitate support and resource access throughout treatment. By integrating digital interventions with pharmaceuticals, Pear Therapeutics aims to improve patient engagement, clinical outcomes, and cost-effectiveness in healthcare.

Gaiaworks

Series D in 2020
GaiaWorks is a developer of a cloud-based workforce management platform designed to enhance operational efficiency for organizations. The company’s solution integrates various functionalities, including time and attendance tracking, intelligent scheduling, and labor optimization, to simplify compliance and control labor costs. By utilizing data prediction based on the analysis of historical business metrics, such as sales volume and transaction numbers, GaiaWorks enables businesses to forecast labor needs effectively, typically on a weekly basis. This approach helps organizations improve labor efficiency, mitigate compliance risks, and enhance employee satisfaction.

Seismic Software

Series F in 2020
Seismic is a leading provider of sales enablement solutions that assist organizations in enhancing customer engagement and driving revenue growth. Its flagship product, the Seismic Enablement Cloud, is a comprehensive platform designed to equip customer-facing teams with essential skills, content, tools, and insights necessary for success. By automating the creation of personalized sales materials and leveraging data to identify effective content, Seismic improves sales performance by increasing close rates and facilitating larger deals. The company serves a diverse clientele, ranging from large enterprises to startups and small businesses, with over 2,000 organizations worldwide relying on Seismic to meet their enablement needs.

Biofourmis

Series C in 2020
Biofourmis is a biotechnology company based in Boston, Massachusetts, founded in 2015. It specializes in personalized care and therapies through the use of digital therapeutics. The company develops and delivers clinically validated software-based therapeutics that enhance patient outcomes. Biofourmis has created a predictive health analytics platform that analyzes physiology data gathered from clinical-grade wearables. Utilizing artificial intelligence, this platform integrates and interprets continuous physiological data to identify personalized patterns and predict potential clinical exacerbations. By enabling medical professionals to intervene days before critical events occur, Biofourmis aims to improve patient care and provide cost-effective solutions for healthcare providers.

Livspace

Series D in 2020
Livspace is an interior design startup that connects customers with designers, services, and products through its online platform. Founded in 2014 by Anuj Srivastava and Ramakant Sharma, the company specializes in providing end-to-end home interior services, enabling homeowners to discover and personalize a wide range of interior designs for various rooms. Livspace's proprietary design-to-installation platform, launched in 2016, aims to enhance the customer experience by streamlining the renovation process, from initial design concepts to final installation. This comprehensive approach allows customers to efficiently upgrade their homes with tailored solutions, making Livspace a key player in the home décor industry.

Aetion

Series B in 2020
Aetion, Inc. is a healthcare analytics company that specializes in real-world evidence (RWE) and outcomes-based analytics solutions. Founded in 2012 and based in New York City, Aetion develops the Aetion Evidence Platform, which leverages everyday clinical and financial interactions within the healthcare system to generate critical insights about the effectiveness and value of medical treatments. This platform serves a diverse clientele, including life sciences companies, payers, providers, medical device manufacturers, and academic institutions, allowing them to analyze data from various sources such as claims, electronic health records, registries, and clinical trials. Aetion’s patented rapid-cycle analytics technology facilitates real-time collaboration among stakeholders, enabling them to make informed decisions and optimize patient care. The company has formed strategic partnerships with leading organizations, including McKesson, to enhance its offerings and expand its reach in the healthcare sector.

Rigetti Computing

Series C in 2020
Rigetti Computing is a full-stack quantum computing company that designs and manufactures quantum-integrated circuits, which are deployed in low-temperature environments. The company develops control systems that perform quantum logic operations and has created software to seamlessly integrate its quantum systems into existing cloud infrastructures. Rigetti is known for its development of the industry's first multi-chip quantum processor, enabling scalable quantum computing systems. Additionally, the company focuses on practical applications of quantum computing, particularly in computational chemistry and machine learning, and has introduced Forest, a comprehensive programming and execution environment for quantum and classical computing. The majority of its revenue is generated from the United States.

Vesta

Venture Round in 2020
Vesta Corporation is a provider of electronic payment solutions, specializing in client-branded services that enhance payment processing for merchants. The company offers a range of merchant solutions, including vSafe for Small to Midsize Businesses, which focuses on payment and fraud protection for smaller digital goods merchants, and vSafe for Enterprise, designed for comprehensive payments management and enterprise-level fraud prevention. Additionally, Vesta provides vGuaranteed, a payment solution tailored for online retailers, and DelayPay, a retail installment program that allows prepaid wireless customers to pay for services in installments. Founded in 1995 and headquartered in Lake Oswego, Oregon, Vesta operates globally, with centers in the United States, Ireland, China, and an office in Singapore. The company serves diverse industries, including e-commerce, telecommunications, and financial services, processing hundreds of millions of secure payments across various channels while prioritizing data security and fraud loss elimination.

Transcelestial

Series A in 2020
Transcelestial Technologies Pte. Ltd., based in Singapore and established in 2016, specializes in developing a high-speed wireless communication network that utilizes laser technology for point-to-point connections. This innovative network is designed to facilitate data transfer for both terrestrial and satellite applications, achieving speeds up to 1000 times faster than conventional methods. The technology is characterized by its resilience against jamming and its independence from spectrum pre-allocation or regulatory constraints. By creating a robust infrastructure for wireless communication, Transcelestial aims to enhance global connectivity and provide reliable network services across various environments, including ground, satellite, and deep-space applications.

Erasca

Series B in 2020
Erasca, Inc. is a clinical-stage precision oncology company based in San Diego, California, focused on discovering and developing therapies for cancers driven by the RAS/MAPK pathway. Founded in 2018, the company utilizes its artificial intelligence-driven oncology pattern recognition algorithm (OPRA) to analyze extensive datasets and uncover novel tumor biology, which aids in the identification of key oncogenes. Erasca's drug development pipeline includes Naporafenib, a pan-RAF inhibitor with potential applications in NRAS mutant melanoma and other RAS/MAPK pathway-driven tumors, as well as ERAS-007, an oral ERK1/2 inhibitor, and ERAS-601, an oral SHP2 inhibitor. The company aims to provide precision oncology options through collaborations with academic and biopharmaceutical partners, ultimately seeking to offer innovative treatment solutions for patients.

Screening Eagle

Series A in 2020
Screening Eagle Technologies AG is a cloud-based technology platform focused on the intelligent inspection of assets and infrastructure. The company integrates sensors, software, and data to enhance the inspection process, offering solutions for project management, workflow, and data analysis. Its services include industrial surface testing across various sectors such as concrete, road, metal, and automotive. Founded in 2019 and headquartered in Schwerzenbach, Switzerland, Screening Eagle emerged from the merger of Dreamlab, a software and robotics company, and Proceq, a leader in portable sensors with over 65 years of experience in non-destructive testing. The platform aims to provide data-driven inspection and predictive asset healthcare through the use of artificial intelligence and real-time analytical tools, ultimately contributing to the protection and maintenance of the built environment.

Doctor Anywhere

Series B in 2020
Doctor Anywhere is a Singapore-based telehealth company that offers a comprehensive digital platform for on-demand healthcare solutions. It provides quick access to a range of health and wellness services, allowing users to consult licensed medical professionals for diagnoses, medications, and e-prescriptions from anywhere and at any time. The platform is designed to be simple and convenient, catering to the evolving lifestyle preferences of modern users. By leveraging technology, Doctor Anywhere aims to enhance health outcomes and address contemporary healthcare challenges, making it easier for individuals to manage their health according to their specific needs.

ElevateBio

Series B in 2020
ElevateBio, LLC is a holding company based in Cambridge, Massachusetts, founded in 2017. It focuses on developing cell and gene therapies for the treatment of cancer and viral infections. The company operates a portfolio of subsidiaries that aim to manufacture and commercialize innovative medicines. ElevateBio collaborates with leading scientists and inventors to create a robust portfolio of therapeutic solutions. Additionally, it has established a centralized facility designed to streamline the translation of cell and gene therapy research into viable medical products, ensuring that patients have access to treatments for severe diseases in a timely manner.

ShopBack

Series B in 2020
ShopBack is a leading online shopping platform in Southeast Asia that focuses on enhancing consumer purchasing decisions through cashback and rewards. Operating in several countries including Singapore, Malaysia, Indonesia, the Philippines, Thailand, and Taiwan, the company facilitates over 1,000 orders per hour by offering up to 30% cashback on purchases made through its platform. With a portfolio of over 1,300 merchant partners such as Uber, Expedia, and Lazada, ShopBack provides consumers with curated deals while simultaneously delivering effective marketing solutions for its business partners. The company is recognized for its impact in the industry, having received multiple awards, including accolades for Best Start-up and Best Innovative Infocomm Products at the Singapore Infocomm Technology Federation Awards, as well as the Emerging Enterprise Award, highlighting its role in enriching the shopping experience for consumers.

Eko Health

Venture Round in 2020
Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com.

eko.ai

Funding Round in 2020
Eko.ai Pte. Ltd. is a Singapore-based company that specializes in artificial intelligence software aimed at the early detection and treatment of heart disease. Founded in 2017, the company focuses on democratizing echocardiography and ultrasound imaging to enhance cardiovascular risk assessment. Eko.ai employs machine learning to automate processes, providing research teams with fully classified, machine learning-ready databases and a variety of tools, including segmentation and validation models. By collaborating with clinician scientists, sonographers, and deep learning experts, Eko.ai serves laboratories worldwide, aiming to improve productivity and patient outcomes within hospital systems.

SWAT Mobility

Series A in 2019
SWAT Mobility specializes in vehicle-routing technology aimed at addressing complex transportation challenges faced by companies, transport operators, and government agencies globally. The company's innovative solutions utilize advanced artificial intelligence algorithms to optimize route planning and pooling, enhancing transport efficiency while accommodating multiple waypoints. By offering high-capacity vehicle pooling services that are both on-demand and dynamically routed, SWAT Mobility has demonstrated success in reducing transportation costs, improving urban connectivity, and alleviating traffic congestion. Their technology is designed to meet current logistics needs and is well-positioned for future advancements, including the integration of autonomous vehicles.

M-DAQ

Venture Round in 2019
M-DAQ Pte Ltd is an innovative company that specializes in providing a platform for cross-border transactions, enabling users to price and trade exchange-traded products in multiple currencies. Founded by industry veterans with extensive experience in foreign exchange and securities, M-DAQ blends executable foreign exchange rates into equities and futures products. This unique solution allows traders and security exchanges to operate in a multi-currency environment without requiring significant changes to their existing systems and back-end processes. M-DAQ maintains key relationships with national exchanges and global foreign exchange banks and handles the consultancy work necessary for exchanges to utilize its solution. Additionally, partner exchanges can earn revenue through a share of the net foreign exchange margins generated by the platform, all while operating within their respective regulatory frameworks.

Neon Group

Private Equity Round in 2019
Neon Group is a global entertainment company headquartered in Singapore, specializing in creating and producing immersive experiences across various domains, including exhibitions, events, and interior architecture. The company has established partnerships with prominent organizations, including The Walt Disney Company, Marvel Entertainment, 20th Century Studios, and NBCUniversal, to develop popular themed exhibitions such as Marvel Avengers S.T.A.T.I.O.N. and Jurassic World: The Exhibition. Additionally, Neon collaborates with the governments of Peru and Egypt to present unique cultural experiences, showcasing original artifacts through exhibitions like Machu Picchu and Ramses the Great. With a commitment to delivering compelling and memorable experiences, Neon Group has successfully engaged millions of visitors across more than 60 cities worldwide, solidifying its position as a leader in the immersive entertainment industry.

Nuvation Bio

Series A in 2019
Nuvation Bio Inc. is a biopharmaceutical company dedicated to addressing unmet needs in oncology through the development of novel therapies for challenging cancers. Founded in 2018 and headquartered in New York, with an additional office in San Francisco, Nuvation Bio focuses on treating patients whose conditions have not responded to conventional treatments. The company's leading clinical-stage candidate, NUV-868, is a BD2-selective oral small molecule BET inhibitor that targets the BRD4 protein, which plays a crucial role in regulating tumor growth and differentiation. In addition to NUV-868, Nuvation Bio is advancing a proprietary small molecule Drug-Drug Conjugate platform aimed at enhancing therapeutic efficacy. The company’s comprehensive portfolio includes multiple drug development candidates designed to meet the specific needs of cancer patients.

Structo

Series D in 2019
Structo is a digital manufacturing platform specializing in dental 3D printing services. The company has developed a range of application-specific 3D printing resins that complement its advanced hardware technology. By focusing on designing and implementing proprietary technology, Structo offers 3D printers that operate at higher speeds than traditional SLA printers. This innovative approach enables dental businesses to enhance their digital dentistry practices, achieving greater throughput and cost efficiency while maintaining high print quality.

DataRobot

Series E in 2019
DataRobot, Inc. is a Boston-based company that specializes in developing an automated machine learning platform aimed at empowering enterprises to construct predictive models efficiently. Its offerings include DataRobot Cloud, a cloud-based platform for predictive analytics, and DataRobot MLOps, which facilitates the deployment, monitoring, and management of machine learning models across organizations. Additionally, DataRobot Enterprise provides features tailored for large organizations, such as flexible deployment options, governance, and comprehensive support. The company's solutions cater to a diverse clientele, including business analysts, data scientists, executives, and IT professionals across various sectors such as banking, healthcare, and manufacturing. Founded in 2012, DataRobot has expanded its operations internationally, with locations in London, Paris, Kyiv, Tokyo, and Singapore, and maintains a strategic partnership with Snowflake to enhance its offerings.

Inari

Series C in 2019
Inari is a biotechnology company focused on transforming agriculture to positively impact society and the environment. By emphasizing diversity in its operations, Inari fosters innovation aimed at developing a new food system. The company utilizes advanced technology, including predictive design and multiplex gene editing, to maximize the potential of seeds. Its distinctive SEEDesign platform enables the enhancement of various crops tailored to specific geographic conditions, facilitating the creation of innovative agricultural products with clear market strategies.

Circles.Life

Venture Round in 2019
Circles.Life is a digital telecommunications company based in Singapore that aims to transform mobile services by focusing on customer needs. The company provides post-paid mobile and internet data services through subscription-based plans, allowing users to manage their data usage and costs via a customized mobile application. Customers can easily track their data consumption, explore various internet data plans, and switch between options seamlessly. With features like no-contract mobile plans and unlimited bonus data, Circles.Life emphasizes delivering a superior customer experience while offering flexibility and convenience in mobile services.

Biofourmis

Series B in 2019
Biofourmis is a biotechnology company based in Boston, Massachusetts, founded in 2015. It specializes in personalized care and therapies through the use of digital therapeutics. The company develops and delivers clinically validated software-based therapeutics that enhance patient outcomes. Biofourmis has created a predictive health analytics platform that analyzes physiology data gathered from clinical-grade wearables. Utilizing artificial intelligence, this platform integrates and interprets continuous physiological data to identify personalized patterns and predict potential clinical exacerbations. By enabling medical professionals to intervene days before critical events occur, Biofourmis aims to improve patient care and provide cost-effective solutions for healthcare providers.

ShopBack

Series B in 2019
ShopBack is a leading online shopping platform in Southeast Asia that focuses on enhancing consumer purchasing decisions through cashback and rewards. Operating in several countries including Singapore, Malaysia, Indonesia, the Philippines, Thailand, and Taiwan, the company facilitates over 1,000 orders per hour by offering up to 30% cashback on purchases made through its platform. With a portfolio of over 1,300 merchant partners such as Uber, Expedia, and Lazada, ShopBack provides consumers with curated deals while simultaneously delivering effective marketing solutions for its business partners. The company is recognized for its impact in the industry, having received multiple awards, including accolades for Best Start-up and Best Innovative Infocomm Products at the Singapore Infocomm Technology Federation Awards, as well as the Emerging Enterprise Award, highlighting its role in enriching the shopping experience for consumers.

Carro

Series B in 2019
Carro is an automotive marketplace that offers a full-stack service for all aspects of car ownership. It challenges the traditional way of buying and selling of cars through a proprietary pricing algorithm. Carro also provides a range of services that offer everything a car owner needs throughout their car ownership journeys such as an in-house financing solution warranty options and Singapore’s first on-demand roadside recovery platform. The company was founded in 2015 and is headquartered in Singapore.

Zilingo

Series D in 2019
Zilingo is a technology-driven platform founded in 2015 by Ankiti Bose and Dhruv Kapoor, aimed at transforming the fashion supply chain through innovative trade solutions. By digitizing the fashion industry, Zilingo provides a marketplace that connects brands and merchants directly with factories, offering essential tools such as analytics, efficient logistics, and secure payment options. This approach enables entrepreneurs to thrive in a sector that has historically favored a select few, promoting accessibility, transparency, and connection within the fashion ecosystem. Zilingo's vision is to democratize fashion, making it possible for anyone with the right ideas to succeed in the industry.

Pear Therapeutics

Series C in 2019
Pear Therapeutics, Inc. is a healthcare company specializing in the discovery, development, and delivery of software-based therapeutics aimed at treating behavioral health disorders, including addiction, schizophrenia, anxiety, depression, and chronic insomnia. Founded in 2013 and headquartered in Boston, with an additional office in San Francisco, Pear Therapeutics offers a range of digital therapies designed to enhance treatment outcomes. Notable products include reSET, a tool for substance abuse treatment used alongside traditional therapy; reSET-O, which addresses opioid use disorder; and Somryst, aimed at chronic insomnia. The company also provides PearConnect, a patient services center that connects users with advocates, clinicians, and insurance providers to facilitate support and resource access throughout treatment. By integrating digital interventions with pharmaceuticals, Pear Therapeutics aims to improve patient engagement, clinical outcomes, and cost-effectiveness in healthcare.

Pindrop

Series D in 2018
Pindrop is a developer of advanced phone fraud detection and call center authentication technology, focused on enhancing security, identity, and trust in voice interactions. The company offers solutions that authenticate phone devices through call audio analysis, enabling the detection of fraudulent calls and the verification of legitimate callers. By leveraging a comprehensive risk database, Pindrop's technology helps enterprise call centers and businesses streamline communication, reduce call handling time, and improve customer experience while minimizing fraud losses. With a commitment to unlocking the value of voice interactions, Pindrop is positioned to support both enterprises and consumers in navigating a voice-driven future.

WalkMe

Series F in 2018
WalkMe Inc., founded in 2011 and headquartered in San Francisco, California, develops a cloud-based guidance and engagement platform designed to enhance user experience and productivity. Their Digital Adoption Platform adapts software to meet the needs of employees and customers, while WalkMe Automation simplifies user experiences by automating complex tasks. The company also offers solutions for modernizing legacy desktop applications and enhancing security. WalkMe's platform integrates with various systems, including Salesforce and Workday, and serves sectors such as financial services, healthcare, insurance, retail, software, utility, and education. With additional offices in New York, Raleigh, London, Tel Aviv-Yafo, Sydney, and Tokyo, WalkMe is a subsidiary of WalkMe Ltd.

Ambiq Micro

Series E in 2018
Ambiq Micro, Inc. specializes in the development of ultra-low power integrated circuits tailored for power-sensitive applications. The company focuses on creating subthreshold power optimized technology, producing real-time clocks and microcontrollers for various uses, including wearables, smart cards, wireless sensors, and Internet-of-Things (IoT) devices. Founded in 2009 and based in Austin, Texas, Ambiq Micro also maintains offices in San Jose, California, and several locations in China. Its pioneering technology aims to facilitate the creation of next-generation wireless electronics by enabling innovative companies to design products that minimize battery dependency, reduce overall power consumption, and enhance design flexibility. Additionally, Ambiq Micro provides technical support services to its clients, further contributing to its mission of advancing low-power semiconductor solutions.

Moka

Series B in 2018
Moka is a Jakarta-based technology company that specializes in developing a cloud-based point-of-sale application and integrated card reader solutions for small and medium-sized businesses. Founded in 2014, Moka's application enables users to process payments via debit and credit cards while also providing features such as sales reporting across multiple outlets, inventory tracking, customer feedback collection, and analytics. The company offers a range of hardware, including Apple iPads, printers, cash drawers, barcode scanners, and mobile point-of-sale devices, catering to various sectors such as coffee shops, barbershops, retail stores, and restaurants, as well as mobile vendors like food trucks and kiosks. Moka operates on a subscription-based model, charging users a monthly fee that varies according to the number of locations they manage. This approach allows business owners to access real-time sales data stored in the cloud from any location.

OakNorth Bank

Series B in 2018
OakNorth Bank, established in 2015, is a digital-only commercial bank based in London, UK. It specializes in serving small-to-medium sized businesses (SMEs) that are often overlooked by traditional banks. The bank offers a range of financial products, including business and personal savings accounts, fixed term deposits, and property finance solutions. OakNorth's core strength lies in its bespoke debt finance solutions, catering to the growth plans of businesses without requiring equity. It has lent over £10 billion to date, supporting various sectors such as property developers, care homes, and hospitality businesses. The bank's data-led approach enables it to make forward-looking decisions, acting as a reliable, long-term partner to its customers.

I-Mab Biopharma

Series C in 2018
I-Mab Biopharma (Shanghai) Co., Ltd. is a clinical-stage biopharmaceutical company based in Shanghai, China, with additional offices in Beijing and Rockville, Maryland. Founded in 2016, the company focuses on the discovery, development, and commercialization of innovative biologics aimed at addressing significant unmet medical needs, particularly in the fields of immuno-oncology and immuno-inflammation. I-Mab's diverse drug pipeline targets various therapeutic areas, including multiple myeloma, autoimmune diseases, pediatric growth hormone deficiency, and several cancer indications such as head and neck cancer. Key candidates in its portfolio include Uliledlimab, an antibody for solid tumors, along with Ragistomig and Givastomig, highlighting the company's commitment to developing transformative therapies for patients.

Puppet

Series F in 2018
Puppet is an information technology company that specializes in automation solutions aimed at addressing common business challenges. The company offers a comprehensive platform for infrastructure automation, covering areas such as configuration management, compliance, application delivery, and patch management. Puppet's tools facilitate the development, management, version control, and code analysis necessary for effective IT operations. By enabling clients to deliver, update, monitor, and secure software across both physical and virtual machines, Puppet enhances operational efficiency and reliability in IT environments.

BITMAIN

Series B in 2018
Bitmain is a leading manufacturer of Bitcoin mining hardware, specializing in the development and sale of miners utilizing ASIC chip technology. Founded by pioneers in the digital currency sector, the company is staffed by a team of skilled engineers, financial experts, and cryptocurrency enthusiasts. Headquartered in Beijing, Bitmain also maintains offices in cities such as San Francisco, Tel Aviv, Hong Kong, Chengdu, and Shenzhen. The company focuses on providing high-quality, efficient computing solutions, including high-density server equipment and large-scale parallel computing software, to support the cryptocurrency mining industry.

Carousell

Series C in 2018
Carousell is a Singapore-based classifieds marketplace that facilitates the buying and selling of preloved items through its mobile app, available on iOS and Android. Launched in August 2012, the platform allows users to easily list their secondhand goods by simply taking a photo and adding a description, covering a wide array of categories such as fashion, electronics, home goods, and vehicles. Carousell has gained popularity and recognition, ranking as the top shopping app in several regions including Singapore, Taiwan, Hong Kong, and Australia. The company has expanded its reach to 19 cities across seven countries, driven by a mission to inspire individuals to start selling and declutter their lives while enabling others to discover savings.

Rotimatic

Series C in 2018
Zimplistic, founded in 2008 by Rishi Israni and Pranoti Nagarkar, is a kitchen robotics startup focused on improving healthy eating through innovative technology. Its flagship product, Rotimatic, is the world's first fully automatic roti-making appliance that utilizes artificial intelligence and machine learning to prepare fresh, homemade rotis with minimal human intervention. Users can create hot and delicious rotis in under a minute by simply pressing a button, making it a convenient solution for busy households. Since its launch in 2016, Rotimatic has garnered significant global interest, serving millions of rotis across various countries, including Singapore, the US, UK, Canada, Australia, and New Zealand. The appliance stands out for its compact design and user-friendly operation, aiming to simplify meal preparation while promoting healthier eating habits. With its innovative approach, Rotimatic has disrupted the kitchen appliance market and continues to attract health-conscious consumers seeking convenient cooking solutions.

H3 Dynamics

Series B in 2018
H3 Dynamics is a company specializing in high-performance hydrogen solutions tailored for the aerospace and defense sectors. With offices in Toulouse, Austin, and Singapore, H3 Dynamics boasts over 16 years of research and development experience, positioning itself as a pioneer in hydrogen flight technology. The company focuses on advancing hydrogen-electric fuel cell systems for various applications, including extending the operational range of small electric unmanned aerial systems and powering large-scale passenger aircraft. Additionally, H3 Dynamics offers on-site hydrogen production and refueling services for airports and drone operators, particularly in remote locations. The company also develops telerobotics drones that transform complex data from images, videos, and sensor inputs into expert-validated inspection reports, providing essential aerial analytics and delivery services to asset owners and operators.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.